So, if Wegovy or Zepbound are prescribed for a reason other than weight loss such as reducing cardiovascular risk (Wegovy) or treating obstructive sleep apnea (Zepbound) they can be covered
however, it appears from all the STEP trials that weight loss with semaglutide plateaus before the end of 68 weeks of treatment, and that once patients stop semaglutide treatment, they may regain the majority of the weight lost
If you are not 100% sure of your vials concentration or syringe type, confirm with the dispensing pharmacy or your prescribing clinician before injecting
KEY FINDINGS Average weight loss on treatment: 7.9 kg (all GLP-1s) 16.1 kg (newer GLP-1s like semaglutide/tirzepatide) Weight regained after stopping: 0.70.8 kg/month 8.39.6 kg regained in the first year Full return to baseline: 0.9 years (older GLP-1s) 1.7 years (newer GLP-1s) Bottom line: GLP-1s are effective, but without ongoing treatment or structured long-term care, the benefits fade quickly
Morning versus evening administration does not significantly impact efficacy, though some find evening injection helps them sleep through initial nausea
Nhim toan ceton do bnh i tho ng c bo co ngi bnh ph thuc insulin, ngi bnh nhanh chng ngng hay gim liu insulin khi bt u iu tr vi thuc ch vn th th GLP 1